Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina
- PMID: 2866219
Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina
Abstract
Spontaneous increase in platelet activity and change in coronary vasomotor tone have been implicated in the pathogenesis of acute myocardial ischemia. To define the mechanism of platelet "hypersensitivity" in acute myocardial ischemia, we examined the status of platelet alpha 2-adrenergic receptors in patients hospitalized with severe unstable angina. With the use of the specific alpha 2-receptor antagonist 3H-yohimbine, we identified a 26% decrease in the receptor binding sites on platelet membranes from patients with unstable angina compared with controls (155 +/- 32 vs. 210 +/- 29 fmol/mg protein, P less than or equal to 0.005). The dissociation constants of 3H-yohimbine binding to platelet alpha 2-receptors were similar in both groups (3.3 +/- 1.1 and 4.1 +/- 1.6 nmol/L, P not significant). To study the alterations in the affinity of platelet alpha 2-receptors for the agonists, effects of 1-epinephrine on specific binding of 3H-yohimbine were examined. We observed a marked reduction in 1-epinephrine concentration for inhibition of antagonist binding by 50% in acute myocardial ischemia (IC50: 4.2 +/- 3.9 X 10(-8) vs. 6.7 +/- 3.4 X 10(-7) mol/L, P less than or equal to 0.01), indicating increase in platelet alpha 2-receptor affinity for the agonist. Platelet aggregation and thromboxane A2 generation in response to epinephrine were also significantly increased in the acute phase of myocardial ischemia. This study suggests enhanced affinity of platelet alpha 2-receptors to the agonist 1-epinephrine as a possible mechanism of platelet hypersensitivity in acute myocardial ischemia.
Similar articles
-
p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.Mol Pharmacol. 1990 Aug;38(2):214-21. Mol Pharmacol. 1990. PMID: 1974694
-
Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.Thromb Haemost. 1985 Aug 30;54(2):402-8. Thromb Haemost. 1985. PMID: 3001964
-
Platelet activation in unstable coronary disease.N Engl J Med. 1986 Oct 16;315(16):983-9. doi: 10.1056/NEJM198610163151602. N Engl J Med. 1986. PMID: 3531859
-
Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.Rev Port Cardiol. 1994 Dec;13(12):935-46, 893. Rev Port Cardiol. 1994. PMID: 7873224 Review.
-
[Adrenergic receptors of blood platelets].Nouv Rev Fr Hematol (1978). 1987;29(6):407-24. Nouv Rev Fr Hematol (1978). 1987. PMID: 2837727 Review. French.
Cited by
-
Alterations in platelet alpha 2-adrenoceptors by aspirin.Agents Actions. 1988 Jun;24(1-2):196-203. doi: 10.1007/BF01968101. Agents Actions. 1988. PMID: 2841831
-
NPC 15669, an Antiinflammatory Leucine Derivative, Reduces In Vitro Platelet Aggregability in Both Swine and Human Plasma.J Thromb Thrombolysis. 1995;1(2):171-178. doi: 10.1007/BF01062575. J Thromb Thrombolysis. 1995. PMID: 10603527
-
Anaesthesia for coronary artery surgery--a plea for a goal-directed approach.Can J Anaesth. 1993 Dec;40(12):1178-94. doi: 10.1007/BF03009608. Can J Anaesth. 1993. PMID: 8281595 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical